This episode covers an interview with Prof. Joseph Straus, emeritus director of the Max Planck Institute in Munich, about novelty and biotech inventions. We also talk about the fees and recoverable costs of the UPC. The EPO is in talks with the unions. And there has been an amendment of PCT regulations.